A COMPARISON OF LONG TERM OUTCOMES OF CROSS-OVER SINGLE STENTING AND TWO STENTS IN LEFT MAIN BIFURCATION VIA TRANSRADIAL APPROACH  by Liu, Wei & Zhou, Yujie
TCT@ACC-i2: The Interventional Learning Pathway
A1915
JACC April 1, 2014
Volume 63, Issue 12
A coMPArison of long terM outcoMes of cross-oVer single stenting AnD tWo stents in 
left MAin bifurcAtion ViA trAnsrADiAl APProAch
Poster Contributions
Hall C
Monday, March 31, 2014, 9:45 a.m.-10:30 p.m.
Session Title: Left Main, Multivessel, and Bifurcation PCI
Abstract Category: 40. TCT@ACC-i2: Coronary Intervention: Lmain, Multivessel, Bifurcation
Presentation Number: 2112-315
Authors: Wei Liu, Yujie Zhou, Bei Jing An-Zhen hospital, Bei Jing, AL, People’s Republic of China
background:  The outcome of different percutaneous intervention strategy for distal left main (LM) bifurcation via transradial approach (TRA) was 
not clear. This study aims to compare the long-term outcomes of two stents with that of cross-over single stenting using the drug-eluting stent (DES) 
on LM bifurcation lesions via TRA.
Methods:  Subjects were 226 consecutive patients with distal LM bifurcation lesions who underwent cross-over single stenting or bifucation 
stenting using DES via TRA. The patients were divided into 109 patients (48%), in whom the stent was implanted in the main vessel alone with the 
kissing balloon technique performed for the main vessel and side branch (Single-stenting group; S group), and 117 patients ( 52%) , in whom the 
stent was implanted through two stent technique ( T group : Modified crush-stenting 35%, culotte 40%, T stent 25% ). The two groups were compared 
for major adverse cardiac events (MACE) which included target lesion revascularization (TVR), acute myocardial infarction and death.
results:  Procedure success rate was similar between two groups (98.2% vs 96.6%) , Cross over to trans-femoral was low in each group (0% vs 
1.8%) . Over a median follow-up period of 36 months. There were no differences for TLR, with this conducted in 4.6% of S group and 6.1% of T group. 
There was no difference between the groups in MACE with 10.9% in S group and 12.1% in T group. No significant difference was seen in MACE-free 
survival rate at 36 month with 90.9% for S group and 87.4% for T group (P=NS). Sub-group analysis showed that in patients with diabetes, the MACE 
was much higher in T group than S group ( 16.4%, 9.1% P < 0.05 ). 
conclusion:  No differences in long outcomes were revealed in a comparison between cross-over single stenting and two stents in LM stenting via 
TRA. In patients with Diabetes, the MACE rate was much higher in two stents strategy. 
